Genes & Development

Genes & Development is a peer-reviewed academic journal in the field of molecular biology, molecular genetics, cell biology and development. Founded in 1987, the journal is published twice monthly by Cold Spring Harbor Laboratory Press from editorial offices in Woodbury, New York, USA, in association with The Genetics Society. The 2008 impact factor for Genes & Development was 13.623. The journal was ranked fifth in the Molecular Biology and Genetics category over 1999–2004, according to ScienceWatch, with an average of 47 citations per paper. All issues are available online via the journal website as PDFs, with a text version additionally available from August 1997. Content over 6 months old is freely available. Since 1989, its Editor has been Terri Grodzicker (Cold Spring Harbor Laboratory, USA).

Publisher
Cold Spring Harbor Laboratory Press
Country
United States
History
1987–present
Website
http://genesdev.cshlp.org/
Impact factor
13.892 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Genetics

Study reveals new insights into facial birth defects

Mount Sinai researchers have revealed new insights into how the body regulates craniofacial development in newborns, which can sometimes lead to birth defects such as cleft lip or palate.

Oncology & Cancer

Cancer-fighting gene restrains 'jumping genes'

About half of all tumors have mutations of the gene p53, normally responsible for warding off cancer. Now, UT Southwestern scientists have discovered a new role for p53 in its fight against tumors: preventing retrotransposons, ...

Oncology & Cancer

Mutation leading to biological changes may play role in cancer

A new study from McGill University's Goodman Cancer Research Center (GCRC) has revealed significant biological changes in mice expressing an activated, mutant form of the Estrogen Receptor alpha (ER alpha), shedding new light ...

Oncology & Cancer

How loss of single gene fuels deadly childhood brain cancer

Atypical teratoid rhabdoid tumors (ATRT) are a rare, fast-growing form of brain cancer that usually strikes children three years and younger, though they can occur in older children and adults. There are multiple treatments, ...

Medications

Common diabetes drug reverses inflammation in the liver

The diabetes drug metformin—derived from a lilac plant that's been used medicinally for more than a thousand years—has been prescribed to hundreds of millions of people worldwide as the frontline treatment for type 2 ...

Genetics

Novel approach reduces SCA1 symptoms in animal model

Research has shown that a mutation in the ATAXIN-1 gene leads to accumulation of Ataxin-1 (ATXN1) protein in brain cells and is the root cause of a rare genetic neurodegenerative disease known as spinocerebellar ataxia type ...

page 1 from 19